Growth hormone stimulates hepatic IGF-1 production by binding to growth hormone receptors on liver cells, triggering intracellular signaling through the JAK2/STAT5 pathway that upregulates IGF-1 gene expression
912 Most of these are not aggravated or caused by GLP-1 receptor agonists, except possibly gallbladder disease
Lastly, by enhancing insulin sensitivity, they help in better glucose management, which can be crucial for weight loss
27,28 Notably, impairment of the unfolded protein response (UPR), including XBP1 or IRE1 deficiency, has also been implicated in -cell transdifferentiation or dedifferentiation
GSK-3 inhibitors GSK-3 regulates multiple critical intracellular signalling pathways and it has been implicated in the pathogenesis of numerous diseases, including cancer [305], myocardial diseases [306], and neurodegenerative diseases [307]